Clinical Characteristics and Long-Term Outcomes of Patients with Acute Decompensated Heart Failure with Mid-Range Ejection Fraction
| العنوان: | Clinical Characteristics and Long-Term Outcomes of Patients with Acute Decompensated Heart Failure with Mid-Range Ejection Fraction |
|---|---|
| المؤلفون: | Hideo Fujita, Tatsuro Ibe, Kenichi Sakakura, Hiroshi Wada, Yusuke Ugata, Miyuki Ito, Shin-ichi Momomura |
| المصدر: | International Heart Journal. 60:862-869 |
| بيانات النشر: | International Heart Journal (Japanese Heart Journal), 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Male, medicine.medical_specialty, Time Factors, Acute decompensated heart failure, Heart Ventricles, Adrenergic beta-Antagonists, Population, Angiotensin-Converting Enzyme Inhibitors, Disease, 030204 cardiovascular system & hematology, Ventricular Function, Left, Coronary artery disease, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, education, Aged, Mineralocorticoid Receptor Antagonists, Retrospective Studies, Heart Failure, education.field_of_study, Ejection fraction, business.industry, Stroke Volume, General Medicine, Prognosis, medicine.disease, Hospitalization, Echocardiography, Heart failure, Acute Disease, Cardiology, Etiology, Female, Cardiology and Cardiovascular Medicine, Heart failure with preserved ejection fraction, business, Follow-Up Studies |
| الوصف: | According to recent guidelines, a new category of patients with heart failure (HF) with mid-range left ventricular ejection fraction (LVEF) (HFmrEF) (LVEF = 40%-49%) has been defined. The purpose of this study was to investigate the clinical characteristics and long-term outcomes of patients with HFmrEF. This was a single-center, retrospective, observational study in which we examined the clinical characteristics and outcomes of 494 consecutive patients with acute decompensated heart failure who were admitted to our institution between January 2014 and December 2016. Of this population, 282 (57.1%), 75 (15.2%), and 137 (48.6%) patients had heart failure with reduced ejection fraction (HFrEF), HFmrEF, and heart failure with preserved ejection fraction (HFpEF), respectively. Ischemic heart disease was the primary etiology in HFmrEF and HFrEF. At the time of discharge, β-blockers and renin-angiotensin system inhibitors were more frequently prescribed in HFmrEF than in HFpEF. The composite outcome of cardiovascular mortality and HF readmission was significantly lower in HFmrEF than in HFrEF. Further studies are needed to determine the effectiveness of the management of coronary artery disease and cardioprotective medications for HFmrEF. |
| تدمد: | 1349-3299 1349-2365 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343eb25543ac9d960c1edd3fcfd73c5aTest https://doi.org/10.1536/ihj.18-631Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....343eb25543ac9d960c1edd3fcfd73c5a |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 13493299 13492365 |
|---|